California Public Employees Retirement System Myovant Sciences Ltd. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$17.07 - $24.56 $1.51 Million - $2.17 Million	-88,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$20.46 - $25.18 $167,710 - $206,400	-8,197 Reduced 8.5%	88,200 $1.82 Million
Q4 2020 Feb 02, 2021	SELL	$13.8 - $27.62 $24,840 - $49,716	-1,800 Reduced 1.83%	96,397 $2.66 Million
Q3 2020 Nov 05, 2020	BUY	$14.05 - $22.6 $32,315 - $51,980	2,300 Added 2.4%	98,197 $1.38 Million
Q2 2020 Aug 12, 2020	BUY	$7.34 - $20.84 $65,744 - $186,663	8,957 Added 10.3%	95,897 $1.98 Million
Q1 2020 May 12, 2020	BUY	$6.55 - $14.76 $120,520 - $271,584	18,400 Added 26.85%	86,940 $656,000
Q4 2019 Jan 27, 2020	BUY	$4.2 - $19.21 $287,868 - $1.32 Million	68,540 New	68,540 $1.06 Million

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account